Development of beta-amyloid-induced neurodegeneration in Alzheimer's disease and novel neuroprotective strategies.
about
Mechanisms of noise-induced hearing loss indicate multiple methods of prevention.Requirement of aggregation propensity of Alzheimer amyloid peptides for neuronal cell surface binding.Synaptic plasticity in the hippocampus of a APP/PS1 mouse model of Alzheimer's disease is impaired in old but not young mice.Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?Calcium homeostasis and modulation of synaptic plasticity in the aged brain.Oxysterols, cholesterol homeostasis, and Alzheimer disease.Brain site-specific proteome changes in aging-related dementia.Cellular stress response, sirtuins and UCP proteins in Alzheimer disease: role of vitagenesPotential role of glucagon-like peptide-1 (GLP-1) in neuroprotection.Neuroprotective effects of glucose-dependent insulinotropic polypeptide in Alzheimer's disease.The Neuroprotective Effects of Justicidin A on Amyloid Beta25-35-Induced Neuronal Cell Death Through Inhibition of Tau Hyperphosphorylation and Induction of Autophagy in SH-SY5Y Cells.Rosuvastatin and thapsigargin modulate γ-secretase gene expression and APP processing in a human neuroglioma model.Neuroprotective activity and evaluation of Hsp90 inhibitors in an immortalized neuronal cell line.S100b counteracts neurodegeneration of rat cholinergic neurons in brain slices after oxygen-glucose deprivation.Rapid aggregation and assembly in aqueous solution of A beta (25-35) peptide.Pin1 contribution to Alzheimer's disease: transcriptional and epigenetic mechanisms in patients with late-onset Alzheimer's disease.Dysregulation of TrkB Receptors and BDNF Function by Amyloid-β Peptide is Mediated by Calpain.Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease.Diagnostic Biomarkers of Alzheimer's Disease as Identified in Saliva using 1H NMR-Based Metabolomics.
P2860
Q30500834-881F7D44-BB08-4E86-90D3-5BCF6AFB6BECQ33283469-FB1B8EFE-FB8D-4596-96B8-2B593FCC2F8EQ33546364-3673E2F9-4D48-448C-BE66-393F5417DEE4Q34608998-901A2B72-7AB6-4593-AB23-846B0DC6FEA2Q36828241-571C96FA-FE36-4A69-9CAF-699DFE9F966AQ36851164-30E0BEB6-E627-4AB2-A753-6916CEFB6EF8Q37212178-85BD1470-2FCE-4629-9CDC-1C7FE22594FDQ37348049-E87D094F-7904-4D61-9DC7-4C6ED8C71B73Q38039489-E00EB430-BB12-462D-95F3-505ED7FE1E10Q38583347-BF10AB74-5963-4CA0-94A8-7BBF8A20BC12Q38793357-D03920EB-3188-463C-A2DA-D2A90932A1FAQ39638936-EDA4E646-F01B-41DF-88F7-8849556E3DE2Q39896341-0D43F288-253C-4707-A533-F6FF8C470DF4Q40728145-05C5AFFC-7D1F-4D26-A53E-477310E256C4Q45956160-7FD85B11-42BD-47F1-A30F-9AE6AFE0743CQ48702462-7BC95343-2C81-422A-B7B3-C5D0D4887E56Q48769291-04C0D65C-08A4-416C-9D0D-F070041805A3Q49015193-EC659D5C-014F-4380-88F7-6CBD7085F254Q53388944-3F252E36-53EB-41EC-90E2-65695388B829
P2860
Development of beta-amyloid-induced neurodegeneration in Alzheimer's disease and novel neuroprotective strategies.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Development of beta-amyloid-in ...... el neuroprotective strategies.
@ast
Development of beta-amyloid-in ...... el neuroprotective strategies.
@en
type
label
Development of beta-amyloid-in ...... el neuroprotective strategies.
@ast
Development of beta-amyloid-in ...... el neuroprotective strategies.
@en
prefLabel
Development of beta-amyloid-in ...... el neuroprotective strategies.
@ast
Development of beta-amyloid-in ...... el neuroprotective strategies.
@en
P2860
P1476
Development of beta-amyloid-in ...... vel neuroprotective strategies
@en
P2093
Christian Hölscher
P2860
P304
P356
10.1515/REVNEURO.2005.16.3.181
P577
2005-01-01T00:00:00Z